![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/07/02/2907325/0/en/Results-from-Cognition-Therapeutics-Phase-2-SHINE-Study-of-CT1812-in-Mild-to-Moderate-Alzheimer-s-Disease-Accepted-for-Presentation-at-AAIC.html
https://www.globenewswire.com/news-release/2024/04/29/2871142/0/en/Cognition-Therapeutics-Completes-Enrollment-in-Phase-2-SHIMMER-Study-of-CT1812-in-Mild-to-Moderate-Dementia-with-Lewy-Bodies.html